New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- A comparative effectiveness study of various advanced therapies for Crohn's disease found no significant differences in risks ...
(MedPage Today) -- Time-restricted feeding (TRF), a form of intermittent fasting, led to meaningful reductions in clinical disease activity and ...
Therapeutic options for management of Sickle Cell Disease are currently limited Source: www.thehindu.com Medical Disclaimer: This content is shared for ...
The vaccine has been successfully developed, and animal challenge and toxicity studies have been completed Source: www.thehindu.com Medical Disclaimer: This ...
While some attempts have met with success, a panel of doctors and international specialists reiterated recently that obesity should be ...
‘Why did my son get this disease?’: of stigma, poverty and hard-fought battles against leprosy Source: www.thehindu.com Medical Disclaimer: This ...
An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc lowered ...
A total of 196 contacts linked to the confirmed cases have been identified, traced, monitored, and tested. All traced contacts ...
(MedPage Today) -- Nearly half of the CDC databases that traditionally had monthly updates experienced unexplained pauses in 2025, with ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.